| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $370K | -75.3% |
| R&D Expense | $8.9M | +167.6% |
| SG&A Expense | $9.2M | -4.6% |
| Operating Income | -$17.7M | -54.5% |
| Income Tax | $2K | +0.0% |
| Net Income | -$17.3M | -50.8% |
| EPS (Basic) | -$1.98 | -50.0% |
| EPS (Diluted) | -$1.98 | -50.0% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.3M | -46.6% |
| Accounts Receivable | $152K | — |
| Current Assets | $17.0M | -42.3% |
| Total Assets | $20.3M | -39.0% |
| Current Liabilities | $3.7M | +165.4% |
| Total Liabilities | $5.0M | +61.5% |
| Stockholders' Equity | $15.3M | -49.3% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.4M | -46.8% |
| Capital Expenditures | $396K | -3.2% |
| Investing Cash Flow | -$966K | -136.2% |
| Financing Cash Flow | $0 | -100.0% |
| Free Cash Flow | -$12.8M | -44.5% |